Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 21 Dec 2023  |  Global  |  Technology Research

    Technology Advancements in Precision Diagnostics and Testing

    Innovation is driving the era of value-based care and enabling preventive and personalized health.

    Precision diagnosis in today's healthcare is pivotal, tailoring treatment to individual patients based on genetic, molecular, and environmental factors. This targeted approach enhances accuracy, enables early detection and targeted treatment, minimizes trial-and-error treatment, and optimizes therapeutic outcomes. By leveraging advanced technol...

    $4,950.00
  2. 07 Dec 2023  |  Global  |  Technology Research

    Advancements in Next-gen Sequencing and Genomic Analysis

    NGS Platforms and Genomic Analysis to Ensure Transformational Growth of Precision Medicine

    Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...

    $4,950.00
  3. 28 Nov 2023  |  Global  |  Technology Research

    Growth Opportunities in Obesity Drugs and Delivery Platforms

    GLP-1-based Drugs, Along With Injector and Nanomaterial Delivery Platforms, Drive Transformational Industry Growth

    The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...

    $4,950.00
  4. 09 Oct 2023  |  Global  |  Technology Research

    Advances in Mitochondrial Disease Management

    Intensifying R&D and Building a Differentiated Pipeline will Bolster the Rapidly Growing Ecosystem.

    Mitochondria are vital structures in the human body, and they play an active role in several processes. They are widely recognized as the powerhouses of the cell because of their essential function in energy production. In addition, mitochondria have a significant impact on several functions of the human body; as a result, any dysfunction in mitoch...

    $4,950.00
  5. 04 Oct 2023  |  Global  |  Technology Research

    Technology Advances and Growth Opportunities in Laboratory Automation

    Robotics and AI Enable a Paradigm Shift to Remote and Autonomous Lab Work

    Clinical diagnostics, life science research, genomics and proteomics, and drug discovery labs are adopting lab automation solutions to overcome tremendous operational pressure because of the demand for high throughput and shortage of technicians. Solutions that automate pre-analytical, analytical, and post-analytical processes are available. The re...

    $4,950.00
  6. 19 Sep 2023  |  Global  |  Technology Research

    Implications and Growth Opportunities of Metaverse in Healthcare

    High Patient Engagement, Enhanced Efficacy, and Treatment Adherence Will Drive the Metaverse in Healthcare's Transformational Growth

    The metaverse has the potential to transform the healthcare industry. Its applications in healthcare include therapeutics, diagnostics, surgery, and medical education. It enables patients to receive diagnoses, therapy, and remote consultations from the comfort of their homes. Healthcare professionals can leverage the metaverse for a better understa...

    $4,950.00
  7. 31 Jul 2023  |  Global  |  Technology Research

    Healthcare Interoperability: Technology Innovation and Growth Opportunities

    AI-based API Innovation is Improving Healthcare Data Management and Analysis.

    Healthcare interoperability, the ability of different healthcare systems and applications to seamlessly exchange and use patient health data, is critical to advanced, precise, and personalized healthcare. Data interoperability is crucial to advanced, precise, and personalized healthcare; however, achieving interoperability has been a significant ch...

    $4,950.00
  8. 26 Jul 2023  |  Global  |  Technology Research

    Global Epifluidic Diagnostics Technology Advancements and Growth Opportunities

    Disruptive technologies in flexible microfluidics and electronics are driving the development of next-generation devices

    This research service examines the advancements in epifluidic diagnostics technology, identifying the growth opportunities they present for the healthcare industry. Epifluidic diagnostics is an emerging class of wearable diagnostics that enables sweat and interstitial fluid (ISF) analysis through skin-interfaced microfluidic systems. These body-wor...

    $4,950.00
  9. 30 Jun 2023  |  Global  |  Technology Research

    Neonatal Monitoring: Technology Innovation and Growth Opportunities

    AI-enabled Noninvasive Monitoring that Offers Real-time Feedback and Intelligent Decision-making Drives Transformational Growth.

    Neonatal monitoring medical technologies monitor newborn babies’ health and vital signs in the first few days or weeks of their life. These technologies are used in neonatal intensive care units (NICUs) and other hospital settings or at home. Some commonly used neonatal monitoring devices include electrocardiography (ECG) monitors, pulse oximetry...

    $4,950.00
  10. 29 Jun 2023  |  Global  |  Technology Research

    Emerging Landscape of Targeted Protein Degradation Therapeutics

    Rapid Technology Advances Bolster a Robust Therapeutic Pipeline

    This Frost & Sullivan research report provides an in-depth analysis of the emerging targeted protein degradation (TPD) space. TPD strategies enable treating various diseases not yet treatable via conventional approaches by attacking disease-causing proteins in a controlled manner, thus reducing the risk of side effects. It is estimated that 80%...

    $4,950.00